BRPI0607651A2 - composições contendo lignano - Google Patents

composições contendo lignano

Info

Publication number
BRPI0607651A2
BRPI0607651A2 BRPI0607651-3A BRPI0607651A BRPI0607651A2 BR PI0607651 A2 BRPI0607651 A2 BR PI0607651A2 BR PI0607651 A BRPI0607651 A BR PI0607651A BR PI0607651 A2 BRPI0607651 A2 BR PI0607651A2
Authority
BR
Brazil
Prior art keywords
compositions
lignano
containing compositions
lignan
glycosamine
Prior art date
Application number
BRPI0607651-3A
Other languages
English (en)
Inventor
Mark W Empie
Brent D Flickinger
Samz Z Sun
Original Assignee
Archer Daniels Midland Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archer Daniels Midland Co filed Critical Archer Daniels Midland Co
Publication of BRPI0607651A2 publication Critical patent/BRPI0607651A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)

Abstract

COMPOSIçõES CONTENDO LIGNANO. São fornecidas composições que incluem um lignano, e um composto adicional como uma isoflavona, um tocoferol, um fitosterol, um polifenol, uma catequina, uma antocianina, uma astaxantina ou uma glicosamina. As composições podem ser formuladas como um suplemento dietético, em forma de comprimido, pó ou líquido, ou podem ser incorporadas em um produto alimentício. São úteis no tratamento de várias doenças.
BRPI0607651-3A 2005-04-04 2006-04-03 composições contendo lignano BRPI0607651A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66793705P 2005-04-04 2005-04-04
PCT/US2006/012209 WO2006107820A2 (en) 2005-04-04 2006-04-03 Lignan-containing compositions

Publications (1)

Publication Number Publication Date
BRPI0607651A2 true BRPI0607651A2 (pt) 2009-09-22

Family

ID=36636653

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0607651-3A BRPI0607651A2 (pt) 2005-04-04 2006-04-03 composições contendo lignano

Country Status (10)

Country Link
US (1) US20060234948A1 (pt)
EP (1) EP1876914A2 (pt)
JP (1) JP2008537678A (pt)
CN (1) CN101188948A (pt)
AU (1) AU2006232344A1 (pt)
BR (1) BRPI0607651A2 (pt)
CA (1) CA2604595A1 (pt)
IL (1) IL186093A0 (pt)
NO (1) NO20075540L (pt)
WO (1) WO2006107820A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008012106A1 (en) 2006-07-28 2008-01-31 Bioriginal Food & Science Corporation Fat containing composition
JP2008239619A (ja) * 2007-02-28 2008-10-09 Fuji Chem Ind Co Ltd 末梢血行改善組成物
CN101854812B (zh) * 2007-09-14 2014-04-23 Tic树胶公司 超可分散性胶质和粉末以及它们的制备方法
US8283338B2 (en) 2007-11-30 2012-10-09 Kao Corporation GIP secretion inhibitor
SE532965C2 (sv) * 2008-02-06 2010-05-25 Edio Healthcare Ab Förfarande för framställning av mikropartiklar innehållande växtsterol
JP4409617B1 (ja) * 2008-12-04 2010-02-03 富士化学工業株式会社 カロテノイド色素の退色防止方法及びその容器体
CA2751511C (en) 2009-02-23 2017-04-11 Unilever Plc Edible composition for treating cutaneous signs of ageing
US8338389B2 (en) 2009-06-17 2012-12-25 Kao Corporation Agent for preventing or ameliorating obesity
JP4647712B1 (ja) * 2010-04-30 2011-03-09 富士化学工業株式会社 アスタキサンチンを含む練粉焼成食品
ITPI20110034A1 (it) * 2011-04-01 2012-10-02 Funcional Food Res S R L Preparazione alimentare funzionale ad uso femminile.
WO2013075120A1 (en) * 2011-11-18 2013-05-23 Regents Of The University Of Minnesota Methods of treating cancer with herbacetin
JP6051436B2 (ja) * 2011-12-07 2016-12-27 国立研究開発法人産業技術総合研究所 レッドクローバーと亜麻種子由来のエストロゲン類似活性組成物
US20150098978A1 (en) * 2013-10-03 2015-04-09 Altria Client Services Inc. Dissolvable-chewable tablet
EP3171741A1 (en) * 2014-07-21 2017-05-31 Abbott Laboratories Nutrient delivery system
CN108324757A (zh) * 2018-05-17 2018-07-27 山西大学 胡麻多酚的提取方法及抗肿瘤应用
US11173187B2 (en) * 2018-11-13 2021-11-16 Immortazyme Company Ltd. Concentrated oil-based polyphenol composition and a method of producing the oil-based polyphenol composition
CN110367259A (zh) * 2019-06-25 2019-10-25 山东省农业科学院作物研究所 一种小麦玉米周年高产抗逆栽培调控剂及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2234479A (en) * 1936-03-13 1941-03-11 Robert P Scherer Capsule and method of making the same
US2349430A (en) * 1941-05-15 1944-05-23 Eastman Kodak Co Medical capsule
US2387747A (en) * 1944-03-04 1945-10-30 Benjamin C Cowley Machine for and a method of making filled capsules
GB591442A (en) * 1944-07-08 1947-08-18 Kurt Posner Improvements in or relating to the manufacture of capsules containing a liquid
DE1617671C3 (de) * 1967-03-07 1980-07-03 A. Nattermann & Cie Gmbh, 5000 Koeln Weichgelatine-Kapseln mit erhöhter Wärmestabilität
YU36434B (en) * 1969-05-14 1984-02-29 Sanol Arznei Schwarz Gmbh Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
US4028024A (en) * 1974-10-31 1977-06-07 Moreland Stephen T Manufacture of filled capsules or the like
JPS6229515A (ja) * 1985-07-30 1987-02-07 Shinjiro Tsuji 硬カプセル剤のフイルムコ−テイング方法
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5146758A (en) * 1991-03-04 1992-09-15 Herman Norman L Process of producing soft elastic gelatin capsules
GB9226238D0 (en) * 1992-12-16 1993-02-10 Scherer Ltd R P Encapsulation apparatus and process
US5827256A (en) * 1995-04-21 1998-10-27 Kimberly-Clark Worldwide, Inc Tampon having a protective finger sheath and a method of forming
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US6248354B1 (en) * 1999-03-04 2001-06-19 Allergan Sales, Inc. Capsule system
US6767565B2 (en) * 2001-03-22 2004-07-27 Archer Daniels Midland Company Process for obtaining lignan
US20030060420A1 (en) * 2001-09-14 2003-03-27 Rick Heintzman Process for extraction and stabilization of phytoestrogens from flaxseed and product therefrom
KR101029223B1 (ko) * 2002-03-11 2011-04-14 산토리 홀딩스 가부시키가이샤 Ｓｄｇ의 제법 및 그 배합 음식물
US20050079247A1 (en) * 2003-10-14 2005-04-14 Slilaty George E. Food composition and method of making same

Also Published As

Publication number Publication date
AU2006232344A1 (en) 2006-10-12
WO2006107820A2 (en) 2006-10-12
CA2604595A1 (en) 2006-10-12
CN101188948A (zh) 2008-05-28
NO20075540L (no) 2007-11-01
US20060234948A1 (en) 2006-10-19
IL186093A0 (en) 2008-01-20
EP1876914A2 (en) 2008-01-16
JP2008537678A (ja) 2008-09-25
WO2006107820A3 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
BRPI0607651A2 (pt) composições contendo lignano
AR048181A1 (es) Composicion de ingredientes funcionales
WO2004041184A3 (en) Nutraceutical mangosteen composition
BRPI0507593A (pt) composições contendo cis-isÈmeros de um composto carotenóide e processo
IL170834A (en) Imidazo-pyridine derivatives and their use as medicaments
UA94238C2 (ru) Волокна цитрусового фрукта в эмульсиях
MXPA05009015A (es) Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos.
WO2006110862A3 (en) Micelle composition of polymer and passenger drug
GB0514463D0 (en) Use of pinolenic acid
AR060387A1 (es) Suplementos alimenticios y sus usos
PL2083809T3 (pl) Kompozycja dietetyczna lub farmaceutyczna zawierająca tricykliczne diterpeny do leczenia depresji
HK1088894A1 (en) Flavanone compound and uses thereof
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
DE602004024213D1 (en) Aminopropanolderivate
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
TW200510344A (en) Aryl-heteroaromatic products, compositions comprising them and use
WO2007075255A3 (en) Mastic gum composition for use as a dietary supplement in humans and animals
DK1562447T3 (da) Antioxidative sammensætninger
WO2007142984A3 (en) Nutritional formulations and associated methods
EP2125831A4 (en) ISOFLAVONOID OXAZINYL COMPOUNDS, MEDICAMENTS AND USE
WO2007125562A3 (en) Method for the preparation and use of an enriched cyanidine-s-o-beta-glucopyranoside extract and derivatives thereof from fruits and vegetables containing said anthocyanin and method for the purification and use of cyanidine-3-o-beta- glucopyranoside and derivatives thereof obtained
GB0615105D0 (en) Novel compounds
WO2007113007A3 (en) Package containing a polyphenol and their uses
ATE464896T1 (de) Zubereitung enthaltend oxidierte flavonoid- derivate
MX2007010841A (es) 8-pirrolidinobenzimidazoles biciclicos sustituidos, un metodo para su produccion y su uso como medicamentos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/353 (2006.01), A23L 33/105 (2016.01), A23L